Dennis Bourgeault
2020
In 2020, Dennis Bourgeault earned a total compensation of $703.7K as Former Chief Financial Officer at Aurinia Pharmaceuticals, a 21% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $121,992 |
|---|---|
| Option Awards | $399,825 |
| Salary | $88,426 |
| Other | $93,472 |
| Total | $703,715 |
Bourgeault received $399.8K in option awards, accounting for 57% of the total pay in 2020.
Bourgeault also received $122K in non-equity incentive plan, $88.4K in salary and $93.5K in other compensation.
Rankings
In 2020, Dennis Bourgeault's compensation ranked 9,965th out of 13,090 executives tracked by ExecPay. In other words, Bourgeault earned more than 23.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,965 out of 13,090 | 24th |
Division Manufacturing | 4,290 out of 5,620 | 24th |
Major group Chemicals And Allied Products | 1,764 out of 2,253 | 22nd |
Industry group Drugs | 1,544 out of 1,953 | 21st |
Industry Pharmaceutical Preparations | 1,140 out of 1,458 | 22nd |
Source: SEC filing on May 10, 2021.
Bourgeault's colleagues
We found five more compensation records of executives who worked with Dennis Bourgeault at Aurinia Pharmaceuticals in 2020.
2020
Peter Greenleaf
Aurinia Pharmaceuticals
Chief Executive Officer
2020
Max Colao
Aurinia Pharmaceuticals
Chief Commercial Officer
2020
Joe Miller
Aurinia Pharmaceuticals
Chief Financial Officer
2020
Stephen Robertson
Aurinia Pharmaceuticals
General Counsel
2020
Max Donley
Aurinia Pharmaceuticals